Page 37 - MI-2-3
P. 37

Microbes & Immunity                                                    Correlation between VZV and cancer



            79.  Cornel AM, Mimpen IL, Nierkens S. MHC class  I   Breuer J, Cohen JI. In vitro system using human neurons
               downregulation  in  cancer:  Underlying  mechanisms  and   demonstrates that varicella-zoster vaccine virus is impaired
               potential targets for cancer immunotherapy. Cancers (Basel).   for reactivation, but not latency. Proc Natl Acad Sci U S A.
               2020;12(7):1760.                                   2016;113(17):E2403-E2412.
               doi: 10.3390/cancers12071760                       doi: 10.1073/pnas.1522575113
            80.  Horiuchi Y. Th1 regulatory events by infectious pathogens,   90.  Saitoh H, Momma Y, Inoue H, Yajima D, Iwase H. Viable
               herpes zoster and herpes simplex viruses: Prospects for   herpes simplex virus type  1 and varicella-zoster virus in
               therapeutic  options  for  atopic  eczema.  Postepy Dermatol   the trigeminal ganglia of human cadavers.  J  Med Virol.
               Alergol. 2022;39(4):662-667.                       2013;85(5):833-838.
               doi: 10.5114/ada.2022.118920                       doi: 10.1002/jmv.23527
            81.  Jankeel A, Coimbra-Ibraim I, Messaoudi I. Simian varicella   91.  Rahaus M, Desloges N, Wolff MH. Varicella-zoster virus
               virus: Molecular virology and mechanisms of pathogenesis.   requires a functional PI3K/Akt/GSK-3alpha/beta signaling
               Curr Top Microbiol Immunol. 2023;438:163-188.      cascade for efficient replication.  Cell Signal. 2007;19(2):
                                                                  312-320.
               doi: 10.1007/82_2021_241
                                                                  doi: 10.1016/j.cellsig.2006.07.003
            82.  Grose C, Shaban A, Fullerton HJ. Common features between
               stroke following varicella in children and stroke following   92.  Liu X, Cohen JI. Varicella-zoster virus ORF12 protein
               herpes zoster in adults: Varicella-zoster virus in trigeminal   activates the phosphatidylinositol 3-kinase/Akt pathway
               Ganglion. Curr Top Microbiol Immunol. 2023;438:247-272.  to regulate cell cycle progression.  J  Virol. 2013;87(3):
                                                                  1842-1848.
               doi: 10.1007/82_2021_236
                                                                  doi: 10.1128/JVI.02395-12
            83.  Lei B, Wang Z, Shu Q, et al. Observation of varicella zoster
               virus-induced acute retinal necrosis: Viral load detection   93.  Markus A, Lebenthal-Loinger I, Yang IH, Kinchington PR,
               and visual outcome. Eye (Lond). 2022;36(6):1209-1216.  Goldstein RS. An in vitro model of latency and reactivation
                                                                  of varicella zoster virus in human stem cell-derived neurons.
               doi: 10.1038/s41433-021-01609-8
                                                                  PLoS Pathog. 2015;11(6):e1004885.
            84.  Grahn A, Bergstrom T, Runesson J, Studahl M. Varicella-
               zoster  virus  (VZV)  DNA  in  serum  of  patients  with  VZV      doi: 10.1371/journal.ppat.1004885
               central nervous system infections.  J  Infect. 2016;73(3):   94.  Karin M, Gallagher E. From JNK to pay dirt: Jun kinases,
               254-260.                                           their biochemistry, physiology and clinical importance.
                                                                  IUBMB Life. 2005;57(4-5):283-295.
               doi: 10.1016/j.jinf.2016.04.035
                                                                  doi: 10.1080/15216540500097111
            85.  Richter ER, Dias JK, Gilbert JE 2 , Atherton SS. Distribution
                                      nd
               of herpes simplex virus type  1 and varicella zoster virus   95.  Zapata HJ, Nakatsugawa M, Moffat JF. Varicella-zoster
               in ganglia of the human head and neck.  J  Infect Dis.   virus infection of human fibroblast cells activates the c-Jun
               2009;200(12):1901-1906.                            N-terminal kinase pathway. J Virol. 2007;81(2):977-990.
               doi: 10.1086/648474                                doi: 10.1128/JVI.01470-06
            86.  Smith RL, Pizer LI, Johnson EM Jr., Wilcox CL. Activation of   96.  Kurapati S, Sadaoka T, Rajbhandari L,  et al. Role of the
               second-messenger pathways reactivates latent herpes simplex   JNK pathway in varicella-zoster virus lytic infection and
               virus in neuronal cultures. Virology. 1992;188(1):311-318.  reactivation. J Virol. 2017;91(17):e00640-17.
               doi: 10.1016/0042-6822(92)90760-m                  doi: 10.1128/JVI.00640-17
            87.  Thellman NM, Botting C, Madaj Z, Triezenberg SJ. An   97.  Kuper H, Adami HO, Trichopoulos D. Infections as a
               immortalized human dorsal root ganglion cell line provides   major preventable cause of human cancer.  J  Intern  Med.
               a novel context to study herpes simplex virus 1 latency and   2000;248(3):171-183.
               reactivation. J Virol. 2017;91(12):e00080-17.
                                                                  doi: 10.1046/j.1365-2796.2000.00742.x
               doi: 10.1128/JVI.00080-17
                                                               98.  Sen N, Che X, Rajamani J,  et al. Signal transducer and
            88.  Cohrs RJ, Badani H, Baird NL, White TM, Sanford B,   activator of transcription 3 (STAT3) and survivin induction
               Gilden D. Induction of varicella zoster virus DNA replication   by varicella-zoster virus promote replication and skin
               in dissociated human trigeminal ganglia.  J  Neurovirol.   pathogenesis.  Proc Natl Acad Sci U S A. 2012;109(2):
               2017;23(1):152-157.                                600-605.
               doi: 10.1007/s13365-016-0480-1                     doi: 10.1073/pnas.1114232109
            89.  Sadaoka T, Depledge DP, Rajbhandari L, Venkatesan A,   99.  Ho JD, Xirasagar S, Lin HC. Increased risk of a cancer


            Volume 2 Issue 3 (2025)                         29                               doi: 10.36922/mi.8320
   32   33   34   35   36   37   38   39   40   41   42